Abstract
There is significant evidence that cannabinoids have the ability to exert immunomodulatory effects. The identification of cannabinoid receptors in immune tissues has therefore led to questions about whether these immunomodulatory effects occur via these cannabinoid receptors. The cannabinoid receptor 1 (CB1), although expressed primarily in the brain, is also expressed in lower amounts in peripheral tissues. Of interest to us is the fact that CB1 is expressed in immune tissues such as spleen, albeit at lower levels than the peripheral cannabinoid receptor, CB2. To examine the function of CB1 in immune cells, activation experiments were performed using different stimuli e.g., anti-CD3, phorbol 12-myristate 13-acetate (PMA)/Ionomycin (Io), and PMA/Io + IL-2. Whole spleen cells were cultured in the presence of different stimuli for 0, 2, 4, and 24 hours, harvested at each time point, RNA isolated, and RT-PCR performed. FACS analysis was also performed using CD69 (an early activation marker) to determine whether cells were actually being activated. Results from anti-CD3 stimulation indicated a decrease in CB1 mRNA expression following activation. CB1 mRNA expression in murine splenocytes that were stimulated with PMA/Io in the presence or absence of IL-2 was also modulated. Expression of the message was enhanced upon stimulation with PMA/Io and PMA/Io + IL-2, however, stimulation with PMA/Io + IL-2 led to a stronger increase within 2 to 4 hours with CB1 returning to at or below baseline levels by 24 hours. Expression of CD69 was detected in all stimulated samples thereby indicating that the splenocytes were becoming activated. In summary, anti-CD3 stimulation appeared to decrease CB1 mRNA expression while PMA/Io + IL-2 stimulation significantly increased CB1 mRNA expression. These results demonstrate that the expression of CB1 mRNA is modulated upon cellular activation and that this modulation is dependent on the stimulus that is used.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Matsuda, L.A., et al., Structure of cannabinoid receptor and functional expression of the cloned cDNA. Nature, 1990. 346: p. 561–564.
Gerard, C.M., et al., Molecular cloning of a human cannabinoid receptor which is also expressed in testis. Biochem. J., 1991. 279: p. 129–134.
Chakrabarti, A., E. Onaivi, and G. Chaudhuri, Cloning and sequencing of a cDNA encoding the mouse brain-type cannabinoid receptor protein. DNA Sequence, 1995. 5: p. 385–388.
Nahas, G.G., et al., Inhibition of cellular mediated immunity in marihuana smokers. Science, 1974. 183: p. 419–420.
Luo, Y.D., et al., Effects of cannabinoids and cocaine on the mitogen-induced transformations of lymphocytes of human and mouse origins. Int J Immunopharmac, 1992. 14: p. 49–56.
Blanchard, D.K., et al., In vitro and in vivo suppressive effects of delta-9-tetrahydrocannabinol on interferon production by murine spleen cells. Int. J. Immunopharm., 1986. 8: p. 819–824.
Klein, T.W., et al., Marijuana components suppress induction and cytolytic function of murine cytotoxic T cells in vitro and in vivo. J Toxicol Environ Health, 1991. 32: p. 465–477.
Herkenham, M., et al., Cannabinoid receptor localization in brain. Proc. Natl, Acad. Sci. USA., 1990. 87: p. 1932–1936.
Matsuda, L.A., T.I. Bonner, and S.J. Lolait, Localization of cannabinoid receptor mRNA in rat brain. J Comp Neurol, 1993. 327(4): p. 535–50.
Galiegue, S., et al., Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur J Biochem, 1995. 232(1): p. 54–61.
Gerard, C.M., et al., Molecular cloning of a human cannabinoid receptor which is also expressed in testis. Biochem J, 1991. 279 (Pt 1): p. 129–34.
Kaminski, N.E., et al., Identification of a functionally relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoid-mediated immune modulation. Mol Pharmacol, 1992. 42(5): p. 736–42.
Shire, D., et al., An amino-terminal variant of the central cannabinoid receptor resulting from alternative splicing [published erratum appears in J Biol Chem 1996 Dec 27;271(52):33706]. J Biol Chem, 1995. 270(8): p. 3726–31.
Noe, S.N., et al., Cannabinoid receptor agonists enhance syncytia formation in MT-2 cells infected with cell free HIV-lMN. Adv Exp Med Biol, 1998. 437: p. 223–9.
Ehlers, S., et al., Kinetic analysis of cytokine gene expression in the livers of naive and immune mice infected with Listeria monocytogenes. The immediate early phase in innate resistance and acquired immunity. J Immunol, 1992. 149(9): p. 3016–22.
Daaka, Y., H. Friedman, and T.W. Klein, Cannabinoid receptor proteins are increased in Jurkat, human T-cell line after mitogen activation. J. Pharmacol. Exp. Ther., 1996. 276: p. 776–783.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Kluwer Academic Publishers
About this chapter
Cite this chapter
Noe, S.N., Newton, C., Widen, R., Friedman, H., Klein, T.W. (2002). Modulation of CB1 mRNA upon Activation of Murine Splenocytes. In: Friedman, H., Klein, T.W., Madden, J.J. (eds) Neuroimmune Circuits, Drugs of Abuse, and Infectious Diseases. Advances in Experimental Medicine and Biology, vol 493. Springer, Boston, MA. https://doi.org/10.1007/0-306-47611-8_25
Download citation
DOI: https://doi.org/10.1007/0-306-47611-8_25
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-46466-9
Online ISBN: 978-0-306-47611-2
eBook Packages: Springer Book Archive